Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07670897 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 26, 2026 (before its estimated July 29, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a single-center, open-label, randomized, single-dose bioequivalence trial conducted in healthy adult participants.
Trial Details
NCT Number NCT07670897
Lead Sponsor Gan & Lee Pharmaceuticals.
Conditions T2D
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov